ClinicalTrials.Veeva

Find clinical trials for Prostate Cancer in Charlotte, NC

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Prostatic Cancer
Cancer
Carcinoma
Hypersensitivity
Recurrence
Adenocarcinoma
Castration-Resistant Prostatic Cancer

Prostate Cancer trials near Charlotte, NC, USA:

Randomized Study to Evaluate MACE in Patients With Prostate Cancer Treated With Relugolix or Leuprolide Acetate

This was a randomized study to evaluate the risk of major adverse cardiovascular events (MACE) for relugolix compared with leuprolide acetate. Enroll...

Active, not recruiting
Prostate Cancer
Drug: Leuprolide Acetate
Drug: Relugolix

Phase 3

Sumitomo Pharma
Sumitomo Pharma

Charlotte, North Carolina, United States and 107 other locations

recommended Phase 2 dose (RP2D) and/or maximum tolerated dose (MTD) and preliminary antitumor activity of ORIC-944 in patients with metastatic prostate...

Enrolling
Neuroendocrine Prostate Cancer
Metastatic Prostate Cancer
Drug: ORIC-944

Phase 1

Oric Pharmaceuticals

Charlotte, North Carolina, United States and 5 other locations

of enzalutamide in the treatment of subjects with metastatic prostate cancer. The purpose of this study is to assess if ADT + docet...

Active, not recruiting
Prostate Adenocarcinoma
Prostate Cancer
Drug: ADT+Docetaxel+Enzalutamide

Phase 2

Wake Forest University (WFU)
Wake Forest University (WFU)

Charlotte, North Carolina, United States

Prostate cancer has the second highest incidence rate and is the fifth leading cause of cancer-related deaths among men wo ...

Enrolling
Metastatic Castration-Resistant Prostate Cancer
Drug: ABBV-969

Phase 1

AbbVie
AbbVie

Huntersville, North Carolina, United States of America and 5 other locations

The purpose of this study is to collect long term safety data in subjects who are continuing to derive clinical benefit from treatment with Enzalutam...

Enrolling
Prostate Cancer
Drug: prednisone
Drug: enzalutamide

Phase 2

Astellas
Astellas

Charlotte, North Carolina, United States and 220 other locations

The purpose of this study is to evaluate the efficacy and safety of apalutamide in adult men with high-risk non-metastatic castration-resistant prostate...

Active, not recruiting
Prostatic Neoplasms
Drug: Placebo
Drug: Apalutamide

Phase 3

Aragon Pharmaceuticals

Concord, North Carolina, United States and 388 other locations

The purpose of this study is to compare any good and bad effects of using radium-223 along with docetaxel chemotherapy treatment versus using docetax...

Enrolling
Prostate Cancer
Drug: Radium-223
Drug: Docetaxel 60 mg/m2

Phase 3

Memorial Sloan Kettering Cancer Center (MSK)
Memorial Sloan Kettering Cancer Center (MSK)

Monroe, North Carolina, United States and 62 other locations

This is a randomized, open-label, three-arm, phase 3 study in men with biochemically recurrent prostate cancer and PSA doubling tim...

Active, not recruiting
Prostate Cancer
Drug: Prednisone
Drug: Apalutamide

Phase 3

Alliance Foundation Trials

Charlotte, North Carolina, United States and 68 other locations

The purpose of this study was to evaluate the efficacy of enzalutamide plus androgen deprivation therapy (ADT) as measured by radiographic progressio...

Active, not recruiting
Metastatic Hormone Sensitive Prostate Cancer
Drug: Placebo
Drug: Enzalutamide

Phase 3

Astellas
Astellas

Charlotte, North Carolina, United States and 202 other locations

prednisone in treating patients with castration-resistant metastatic prostate cancer. Androgens can cause the growth of prostate...

Active, not recruiting
Hormone-resistant Prostate Cancer
Stage IV Prostate Cancer
Drug: prednisone
Drug: enzalutamide

Phase 3

Alliance for Clinical Trials in Oncology
Alliance for Clinical Trials in Oncology

Charlotte, North Carolina, United States and 538 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems